French industry welcomes moves to boost the biopharmaceutical sector
This article was originally published in SRA
Executive Summary
The prospects for the French pharmaceutical and biotech sector are looking decidedly rosier than they have done for some time – at least if recent announcements by a joint government/industry body are anything to go by1.